Article ; Online: SGLT2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes.
2023 Volume 176, Issue 3, Page(s) JC27
Abstract: Source citation: Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium. ...
Abstract | Source citation: Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium. |
---|---|
MeSH term(s) | Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Hypoglycemic Agents/adverse effects ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Kidney ; Heart |
Chemical Substances | Sodium-Glucose Transporter 2 Inhibitors ; Hypoglycemic Agents |
Language | English |
Publishing date | 2023-03-07 |
Publishing country | United States |
Document type | Meta-Analysis ; Journal Article ; Comment |
ZDB-ID | 336-0 |
ISSN | 1539-3704 ; 0003-4819 |
ISSN (online) | 1539-3704 |
ISSN | 0003-4819 |
DOI | 10.7326/J23-0002 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.178/2: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.